Login
Navigate Fool.com
Will TEVA beat
the market?
Community Rating: 4 Stars: Favorite

49.91 0.30 (0.60%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.04
Previous Close $49.61
Daily Range $49.90 - $50.52
52-Week Range $36.26 - $54.70
Market Cap $47.3B
P/E Ratio 33.30
Dividend (Yield) $1.17 (2.2%)
Ex-Dividend Date
Dividend Pay Date
02/20/14
03/10/14
Volume 6,623,226
Average Daily Volume 7,016,331
Current FY EPS $4.69

How do you think TEVA
will perform against the market?

Top TEVA Bull/Bear Pitches

 

forexnutca (< 20)
Submitted August 8, 2011

TEVA at 36!? Are you kidding me!....this company makes 80% of their revenues from generics! Deals in 32 currencies around the world, has industry leading world wide manufacturing, first to file on m … More

2 Replies Reply Report this Post
 

angel696i (0)
Submitted July 21, 2009

TEVA is a "defensive" stock. not something that will boost your portfolio when the market goes bull. people think its Generics, but 30% from TEVA's income is from ethics products - copaxone (for MS) a … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

Wednesday’s Top Health Care Stories: Zogenix, Endo, and Teva

Zogenix, Endo, and Teva could make waves across the health sector this Wednesday morning.

Down 17%: Is Isis Pharmaceuticals Worth Buying Now?

Despite a deep product pipeline of intriguing RNAi drugs, shares in Isis (ISIS) have toppled this year. Here's what you need to know about Isis and the catalysts likely to move its shares in the coming year.

Tuesday’s Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax

Johnson & Johnson, Teva, Mylan, and Dynavax could all loom large in health care headlines this Tuesday morning.

The Supreme Court Will Decide the Fate of a Blockbuster

Teva's day in court is coming.

Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?

Let's see what the numbers say about Teva (TEVA).

This Is the Toughest Part of Investing

Keeping your wits about you while the market moves sharply against you.

Can Perrigo Company PLC Continue Its Bull Run?

Perrigo has leveraged a dominant position in store-brand OTC healthcare into good margins, returns, and cash flow.

More Trouble Looming for Amarin Corporation?

Teva announced yesterday that it's launching a generic version of GlaxoSmithKline's Lovaza. Will this launch hurt Amarin's competing product?

Pfizer Blockbuster Zyvox Under Attack

Incoming competition for Pfizer's $1.4 billion Zyvox market is threatening on multiple fronts.

This Dividend Portfolio Continues to Dominate

It's ahead of the market, even though that's not its primary focus. Let's talk about the latest from Union Pacific, Genuine Parts, and Raytheon.

See More TEVA News...

Sector

Healthcare

Industry

Drugs

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks